When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Diffusing capacity for carbon monoxide - Wikipedia

    en.wikipedia.org/wiki/Diffusing_capacity_for...

    This test involves measuring the partial pressure difference between inspired and expired carbon monoxide. It relies on the strong affinity and large absorption capacity of red blood cells for carbon monoxide and thus demonstrates gas uptake by the capillaries that are less dependent on cardiac output. [3]

  3. Diffusing capacity - Wikipedia

    en.wikipedia.org/wiki/Diffusing_capacity

    Diffusing capacity of the lung (D L) (also known as transfer factor) measures the transfer of gas from air in the lung, to the red blood cells in lung blood vessels. It is part of a comprehensive series of pulmonary function tests to determine the overall ability of the lung to transport gas into and out of the blood.

  4. Pulmonary function testing - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_function_testing

    The difference between the highest values of two FVCs need to be within 5% or 150 mL. When the FVC is less than 1.0 L, the difference between the highest two values must be within 100 mL. Lastly, the difference between the two highest values of FEV1 should also be within 150 mL. The highest FVC and FEV1 may be used from each different test.

  5. Talk:Diffusing capacity for carbon monoxide - Wikipedia

    en.wikipedia.org/wiki/Talk:Diffusing_capacity...

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Donate

  6. FEV1/FVC ratio - Wikipedia

    en.wikipedia.org/wiki/FEV1/FVC_ratio

    In obstructive lung disease, the FEV1 is reduced due to an obstruction of air escaping from the lungs. Thus, the FEV1/FVC ratio will be reduced. [4] More specifically, according to the National Institute for Clinical Excellence, the diagnosis of COPD is made when the FEV 1 /FVC ratio is less than 0.7 or [8] the FEV 1 is less than 75% of predicted; [9] however, other authoritative bodies have ...

  7. Lomustine - Wikipedia

    en.wikipedia.org/wiki/Lomustine

    Lomustine can cause or worsen pulmonary infiltrates and fibrosis in patients. Pulmonary toxicity generally occurs after at least 6 months of treatment with lumostine. Lung function should be monitored via Forced Vital Capacity (FVC) or Carbon Monoxide Diffusing Capacity (DLCO) tests to determine patients risk of developing pulmonary toxicities.

  8. Alveolar–arterial gradient - Wikipedia

    en.wikipedia.org/wiki/Alveolar–arterial_gradient

    2, [1] or A–a gradient), is a measure of the difference between the alveolar concentration (A) of oxygen and the arterial (a) concentration of oxygen. It is a useful parameter for narrowing the differential diagnosis of hypoxemia. [2] The A–a gradient helps to assess the integrity of the alveolar capillary unit.

  9. Potassium channel opener - Wikipedia

    en.wikipedia.org/wiki/Potassium_channel_opener

    This pharmacology -related article is a stub. You can help Wikipedia by expanding it.